Dr. James Peyer
James Peyer is a Partner at Apollo Ventures, an early stage life science investment fund focused on breakthrough technologies for treating age-related disease. Apollo works with amazing scientists on groundbreaking therapeutics by investing at the seed stage or helping to start brand new companies. We invest substantial funds to ensure that our portfolio companies can do the best science to advance their programs to the next stage.
He is also a speaker that has delivered keynotes about the intersection of aging research and drug development around the world, in London, Hong Kong, Germany, and the US. He has been a guest lecturer at ETH Zurich and the Max Planck Institute.
Before Apollo, James worked with McKinsey and Company in New York, where he focused on building new biotech companies and developing strategies for valuating and commercializing cell therapies. His focus was on clinical technologies with novel modes of action and substantial development challenges.
During his Ph.D. studies, James co-founded and ran Genotyp, a biotech education startup which became the first biotech company to be funded through Kickstarter.com. He earned his doctorate in stem cell biology in the laboratory of Dr. Sean Morrison at the University of Texas Southwestern in Dallas, where he was a National Science Foundation GRFP Fellow. For his thesis he invented new ways of statistically analyzing three-dimensional relationships between stem cells and their environments. James earned his bachelor’s with special honors from the University of Chicago with a degree in Immunology.